WHO ICTRP trial

The clinical study of azacytidine combined with unrelated cord blood…

ChiCTR2000039928 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR2000039928
Public title The clinical study of azacytidine combined with unrelated cord blood transplantation in the treatment of elderly patients with acute myeloid leukemia
Scientific title The clinical study of azacytidine combined with unrelated cord blood transplantation in the treatment of elderly patients with acute myeloid leukemia
Primary sponsor The First Affiliated Hospital of Anhui Medical University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Interventional study
Countries China
Conditions Acute myeloid leukemia
Interventions The treatment group:azacytidine + cord blood
Registration date Nov 14, 2020
Target size The treatment group:15
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations